Ronisave

Ronisave 4mg/100ml Vial

Zoledronic Acid

MEDISAVE PHARMACEUTICALS

Drug Identity

Active Ingredient
Zoledronic Acid
Drug Class
Drugs For Treatment Of Bone Diseases
ATC Code
M05BA08
Status
Essential Medicine

How It Works

Infuse solution over at least 15 min to prevent renal toxicity. Reconstitute in SWFI. Once fully dissolved, further dilute in 100 ml NS or D5W prior to administration. Infusion of solution must be completed within 24 hours of initial reconstitution of powder. Solution for injection: Dilute in 100 ml NS or D5W prior to administration, Infusion of solution must be completed within 24 hours.

How to Take It

Dosage information not available for this product.

Safety Alerts

Acute gastro-intestinal inflammatory conditions, hypersensitivity to other bisphosphonate

Important Warnings

Atypical femoral fractures, maintain adequate fluid intake during treatment, severe renal and hepatic impairment, cardiac failure
Monitor serum calcium, phosphate, magnesium and renal function
Renal dysfunction reported in patients receiving concomitant NSAIDs

Side Effects

Bronchospasmdiarrhoeanauseahypophosphataemiahypocalcaemiacreatinine/urea increaseanaemiaheadacheconjunctivitisanorexiafatigueskin reactionsvomitingrenal impairmentuveitis. Rare: Atypical femoral fractures

Drug Interactions

Aminoglycosides
thalidomide.

Pregnancy & Lactation

Pregnancy
Contraindicated
Lactation
Contraindicated

Price Intelligence

Rs 32,010.98
DRAP approved maximum price · per unit · approved 27 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
No retail prices recorded

Should you consider an alternative?

Other options containing Zoledronic Acid, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

221
brands
209
molecules
0
alerts

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.